Twin antibodies that may help fight COVID-19 identified


PTI, May 14, 2020, 2:49 PM IST

Beijing: Scientists have identified a pair of neutralizing antibodies isolated from a patient who recovered from COVID-19 — that may offer therapeutic benefits, and help design molecule antivirals and vaccine candidates to fight the SARS-CoV-2 virus.

The antibodies identified by the researchers, including those from the Chinese Academy of Sciences, bind to the glycoprotein spike of the SARS-CoV-2 virus, blocking the spike’s ability to bind to the human ACE2 receptor and mediate viral entry into host cells.

Preliminary tests of the two antibodies, named B38 and H4, in a mouse model, resulted in a reduction of virus titers, the researchers said.

The finding, published in the journal Science, suggests that the antibodies may offer therapeutic benefits — in addition to informing the design of small molecule therapeutics and vaccine candidates to fight COVID-19, they said.

Researcher Yan Wu from Capital Medical University, China, and colleagues found that the antibodies can each bind simultaneously to different epitopes on the spike’s receptor-binding domain (RBD).

“Due to this binding, both antibodies together may confer a stronger neutralizing effect than either antibody on its own a prediction supported by in vitro experiments,” they said.

This feature also means that should one of the viral epitopes mutate in a way that prevents the binding of one of the two antibodies, the other may still retain its neutralizing activity, according to the researchers.

“By imaging, the structure of the viral spike’s RBD bound to B38, the team confirmed that the antibody binds to a subset of the amino acids bound by ACE2,” they said.

This, the researchers explained, provides an explanation for why the B38 antibody confers such strong neutralizing effects.

They suggest that a “cocktail” containing both antibodies could provide direct therapeutic benefits for COVID-19 patients.

“The finding regarding the viral spike epitopes could also aid the development of small molecule antivirals and vaccine candidates to fight the SARS-CoV-2 virus,” the researchers added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

3 killed, 6 injured as truck crushes people sleeping on footpath in Pune

Ambedkar row: Congress to hold nationwide protest against Amit Shah’s remarks

Special trains announced from Bengaluru for Christmas and Kumbh Mela

H D Kumaraswamy announces Rs 15,000 crore revival plan for Bhadravati Visvesvaraya Iron & Steel Factory

Allu Arjun didn’t leave theatre despite being told about woman’s death: Hyderabad police

Kannada Sahitya Sammelana: Food distribution creates stir

Rohit gets hit in nets, practice pitches on slower side

Related Articles More

India & Kuwait elevate ties to strategic level; ink defence pact after PM Modi meets top Kuwaiti leaders

In Kuwait, PM Modi meets yoga practitioner, other influencers from Gulf country

PM Modi receives Kuwait’s highest honour

PM Modi in Kuwait meets translator, publisher of Mahabharata, Ramayana in Arabic

Indian manpower, skills will help build ‘New Kuwait’: PM Modi

MUST WATCH

Tulunadu Daivaradane

Feeding Birds with Creative Paddy Art!

Areca Nut

HOTEL SRI DURGA BHAVANA

Harish Poonja


Latest Additions

3 killed, 6 injured as truck crushes people sleeping on footpath in Pune

Perla Fire Disaster: Five shops completely gutted; Loss estimated at Rs 1.83 crore

Ambedkar row: Congress to hold nationwide protest against Amit Shah’s remarks

Special trains announced from Bengaluru for Christmas and Kumbh Mela

H D Kumaraswamy announces Rs 15,000 crore revival plan for Bhadravati Visvesvaraya Iron & Steel Factory

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.